HB 4965 allows state employees and retirees covered by the Public Employees Insurance Agency (PEIA) to switch to an alternative medical treatment for the same diagnosed condition without needing new pre-approval, provided the alternative is medically appropriate and costs no more than the originally authorized treatment. The bill requires healthcare providers to document the medical necessity of the switch and ensures PEIA cannot deny coverage solely for not having separate pre-approval. It does not change existing covered benefits or affect treatments for new conditions, and PEIA may still deny claims for fraud or improper billing. This policy aims to reduce delays in care while maintaining cost control for the insurance program.
HB 5004 requires Medicaid and private health insurance plans in West Virginia to cover medically necessary diagnosis and treatment for Pediatric Acute-Onset Neuroimmune Disorders (PANS and PANDAS), as defined by the National Institutes of Health. This directly affects Medicaid enrollees and patients with these conditions, ensuring coverage for diagnostic testing, medications, immune-related treatments, and behavioral services when ordered by a physician and supported by medical evidence. The bill mandates coverage parity for behavioral symptoms, preventing insurers from restricting care solely due to psychiatric manifestations. It also requires the state health department to educate providers on recognizing PANS/PANDAS symptoms, including acute onset, association with strep infections, and neurological symptoms. The legislation applies to all health benefit plans subject to West Virginia's insurance laws.
This bill exempts the West Virginia Department of Health from certain state purchasing restrictions when implementing the federal Rural Health Transformation Program. The legislation allows the state to use federal funds more flexibly to meet the program's strict requirements for rapid deployment and specific use of money in rural healthcare areas. By overriding existing state purchasing laws, the bill ensures the Department of Health can comply with federal guidelines from the Centers for Medicare and Medicaid Services without administrative delays. This change directly affects the state's ability to manage federal grants aimed at improving healthcare infrastructure and services in rural communities.
HB 4610 allows terminally ill patients in West Virginia to access experimental, individually tailored medical treatments (like gene therapies) when standard FDA-approved options have been exhausted. It defines "eligible patients" as those with life-threatening illnesses who have consulted a physician, considered all approved treatments, and provided written consent detailing treatment risks and alternatives. Key provisions require healthcare providers to document patient eligibility, obtain specific informed consent covering potential outcomes, and prohibit debt collection from estates if a patient dies during treatment. The bill also protects healthcare providers from sanctions for offering these treatments and clarifies that it does not affect health insurers' obligations to cover clinical trial participation.
HB 5277 is a funding bill that allocates $1 million to Welch Community Hospital, $3.4 million to William R. Sharpe Jr. Hospital, and $4.3 million to Mildred Mitchell-Bateman Hospital from West Virginia's unappropriated surplus balance. These funds are designated specifically for capital improvements, repairs, and equipment at each hospital during fiscal year 2026. The bill supplements existing appropriations by adding these new funding lines to the hospitals' respective budgets. It directly affects the three named hospitals by providing additional resources for facility maintenance and infrastructure. The bill does not create new policies or programs but reallocates existing surplus funds for capital purposes.
This bill (SB 831) reallocates $200,000 within an existing budget line for West Virginia's Department of Human Services Community Mental Health Services (Fund 8794). It decreases funding from the "Federal Coronavirus Pandemic" account and increases funding for "Personal Services and Employee Benefits" to cover staffing costs. The bill does not create new programs or change eligibility for services - it simply shifts existing federal funds between two internal budget categories. This adjustment affects how the Department of Human Services allocates resources for mental health services within its current fiscal year budget.
SB 828 is a procedural bill that allocates unspent funds from the Department of Human Services' Medicaid State Share Fund (Fund 5090) for fiscal year 2026. It directs $174,483,090 already designated for "Medical Services" to cover ongoing Medicaid provider payments, using money remaining unappropriated after the fiscal year began. This bill does not create new policy or change eligibility - it simply ensures existing unspent Medicaid funds are used for medical services as intended. It directly affects Medicaid providers in West Virginia by securing payment for covered services.
SB 741 expands the pilot program for involuntary commitment processes to include additional counties: Cabell, Berkeley, Hampshire, Morgan, Ohio, and Wood. The bill requires mental health centers in these counties to provide timely evaluations (in-person or via video) for potential commitment and explain the process to affected individuals. It also mandates quarterly audits of commitment applications to ensure clinical justification, with findings kept confidential. This bill directly affects mental health centers, courts, law enforcement, and individuals subject to involuntary commitment in the expanded counties.
This bill allows doctors in West Virginia to legally prescribe, distribute, and market specific forms of psilocybin once the FDA approves it and the DEA reschedules it. It amends state pharmacy laws to remove barriers for FDA-approved crystalline polymorph psilocybin products, aligning state regulations with federal decisions. The law applies only to pharmaceutical compositions of psilocybin that meet federal approval standards, not to raw or unapproved forms of the substance. Healthcare providers and pharmacies would be able to handle these medications under existing prescription drug frameworks once federal requirements are met.
SB 650 amends West Virginia law to define a psychiatric hospital treating exclusively civil and forensic patients (with over 95% of its inpatient census being court-ordered forensic or civil involuntary commitments from state custody) as a "state-designated facility" for tax purposes. This change excludes such hospitals from the category of "eligible acute care hospitals" subject to a 0.75% tax on gross receipts, exempting them from this tax. The bill directly affects psychiatric hospitals in West Virginia meeting this specific patient mix requirement by altering their tax classification under the Medicaid funding structure.
